Class Action Lawsuits Targeting CVS Health
Contact Levi Korsinsky for Lawsuit Updates
September 10, 2024 Deadline to Join
New York, New York - May 2, 2024 - Levi Korsinsky LLP is notifying investors in CVS Health Corporation ("CVS" or the "Company") of a class action lawsuit filed on behalf of shareholders who purchased or otherwise acquired common stock between March 8, 2021, and April 8, 2023.
The lawsuit alleges that CVS and certain of its officers and directors violated the federal securities laws by making false and/or misleading statements and/or failing to disclose that:
- CVS was improperly diverting opioids into the illegal drug market.
- CVS failed to take appropriate steps to prevent the diversion of opioids.
- CVS's conduct exposed the Company to substantial legal and financial risks.
If you purchased or otherwise acquired common stock of CVS during the period between March 8, 2021, and April 8, 2023, you may be eligible to participate in the class action lawsuit. The deadline to join the lawsuit is September 10, 2024.
Levi Korsinsky LLP has been recognized as a Top 50 class action firm for seven consecutive years by ISS Securities Class Action Services. Our attorneys have extensive experience representing investors and have recovered billions of dollars for clients. If you have any questions about the lawsuit or would like to learn more about your rights, please contact us today.
Contact:
Levi Korsinsky, Managing Partner
Levi Korsinsky LLP
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
lkorsinsky@korsinskylaw.com
Komentar